Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026)

Elutia's (ELUT) quarterly Liabilities and Shareholders Equity came in at $55.2 million in Q1 2026, up 40.49% year-on-year from $39.3 million in Q1 2025, and down 11.45% quarter-over-quarter from $62.4 million in Q4 2025.

Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Elutia has disclosed Liabilities and Shareholders Equity across 8 years of filings, most recently posting $55.2 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $55.2 million, up 40.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.8 million (up 9.1% YoY), and the FY2025 annual result was $62.4 million, up 72.59% from the prior year.
  • Liabilities and Shareholders Equity came in at $55.2 million for Q1 2026 at Elutia, down from $62.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $68.8 million in Q4 2022 to a low of $29.4 million in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $52.3 million (2023), against an average of $49.1 million.
  • Across the five-year window, Liabilities and Shareholders Equity slumped 41.68% in 2024 and surged 72.59% in 2025, its largest moves.
  • Elutia's Liabilities and Shareholders Equity stood at $68.8 million in 2022, then sank by 36.92% to $43.4 million in 2023, then slipped by 16.81% to $36.1 million in 2024, then soared by 72.59% to $62.4 million in 2025, then slipped by 11.45% to $55.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $55.2 million (Q1 2026), $62.4 million (Q4 2025), and $29.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Elutia 45.15 Mn 16.66 Mn 1.80 Mn 55.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.21 Mn
Dec 31, 2025 62.35 Mn
Sep 30, 2025 29.41 Mn
Jun 30, 2025 33.85 Mn
Mar 31, 2025 39.30 Mn
Dec 31, 2024 36.13 Mn
Sep 30, 2024 48.41 Mn
Jun 30, 2024 41.90 Mn
Mar 31, 2024 35.36 Mn
Dec 31, 2023 43.43 Mn
Sep 30, 2023 54.58 Mn
Jun 30, 2023 52.33 Mn
Mar 31, 2023 60.63 Mn
Dec 31, 2022 68.84 Mn
Sep 30, 2022 61.02 Mn
Jun 30, 2022 52.85 Mn
Mar 31, 2022 59.93 Mn
Dec 31, 2021 67.17 Mn
Sep 30, 2021 59.90 Mn
Jun 30, 2021 69.70 Mn